Vivimed Labs Limited (VIVIMEDLAB) Stock Statistics & Valuation Metrics

Vivimed Labs Limited has a market cap or net worth of ₹479.24M. The enterprise value is ₹4.33B.

Vivimed Labs Limited has 82,913,910 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vivimed Labs Limited’s return on equity (ROE) is 0.91 and return on invested capital (ROIC) is -4.03%.

The current PE Ratio of Vivimed Labs Limited is ―. Vivimed Labs Limited’s PEG ratio is 0.04.

In the last 12 months, Vivimed Labs Limited had revenue of 1.16B and earned -319.61M in profits. Earnings per share was -3.85.

In the last 12 months, operating cash flow was -161.74M and capital expenditures 0.00, giving a free cash flow of -161.74M billion.

Vivimed Labs Limited pays an annual dividend of ₹0.4, resulting in a dividend yield of ―

Vivimed Labs Limited upcoming earnings date is Aug 7, 2026, TBA (Confirmed).

Vivimed Labs Limited as a current ratio of 0.80, with Debt / Equity ratio of -800.71%

In the past 12 months, Vivimed Labs Limited has paid 1.13M in taxes.

Vivimed Labs Limited EV to EBITDA ratio is -48.02, with an EV/FCF ratio of -48.30.

Vivimed Labs Limited has ₹489.84M in cash and marketable securities with ₹3.84B in debt, giving a net cash position of -₹3.35B billion.

Gross margin is 27.19%, with operating margin of -28.62%, and net profit margin of -27.49%.

The average price target for Vivimed Labs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―